Metabolic control analysis of hepatic glycogen synthesis in vivo

Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):8166-8176. doi: 10.1073/pnas.1921694117. Epub 2020 Mar 18.

Abstract

Multiple insulin-regulated enzymes participate in hepatic glycogen synthesis, and the rate-controlling step responsible for insulin stimulation of glycogen synthesis is unknown. We demonstrate that glucokinase (GCK)-mediated glucose phosphorylation is the rate-controlling step in insulin-stimulated hepatic glycogen synthesis in vivo, by use of the somatostatin pancreatic clamp technique using [13C6]glucose with metabolic control analysis (MCA) in three rat models: 1) regular chow (RC)-fed male rats (control), 2) high fat diet (HFD)-fed rats, and 3) RC-fed rats with portal vein glucose delivery at a glucose infusion rate matched to the control. During hyperinsulinemia, hyperglycemia dose-dependently increased hepatic glycogen synthesis. At similar levels of hyperinsulinemia and hyperglycemia, HFD-fed rats exhibited a decrease and portal delivery rats exhibited an increase in hepatic glycogen synthesis via the direct pathway compared with controls. However, the strong correlation between liver glucose-6-phosphate concentration and net hepatic glycogen synthetic rate was nearly identical in these three groups, suggesting that the main difference between models is the activation of GCK. MCA yielded a high control coefficient for GCK in all three groups. We confirmed these findings in studies of hepatic GCK knockdown using an antisense oligonucleotide. Reduced liver glycogen synthesis in lipid-induced hepatic insulin resistance and increased glycogen synthesis during portal glucose infusion were explained by concordant changes in translocation of GCK. Taken together, these data indicate that the rate of insulin-stimulated hepatic glycogen synthesis is controlled chiefly through GCK translocation.

Keywords: glucokinase; hepatic glycogen synthesis; hepatic insulin resistance; in vivo; metabolic control analysis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diet, High-Fat / adverse effects
  • Disease Models, Animal
  • Fatty Liver / etiology
  • Fatty Liver / pathology*
  • Gene Knockdown Techniques
  • Glucokinase / genetics
  • Glucokinase / metabolism*
  • Glucose / administration & dosage
  • Glucose / metabolism*
  • Glucose-6-Phosphate / analysis
  • Glucose-6-Phosphate / metabolism
  • Humans
  • Hyperglycemia / etiology
  • Hyperglycemia / pathology
  • Hyperinsulinism / etiology
  • Hyperinsulinism / pathology
  • Insulin / metabolism
  • Insulin Resistance
  • Liver / metabolism*
  • Liver / pathology
  • Liver Glycogen / biosynthesis*
  • Male
  • Metabolomics
  • Phosphorylation
  • Rats

Substances

  • Insulin
  • Liver Glycogen
  • Glucose-6-Phosphate
  • Glucokinase
  • Glucose